Trademark: 90840013
Word
ETAGCLU
Status
Pending
Status Code
732
Status Date
Wednesday, January 3, 2024
Serial Number
90840013
Mark Type
4000
Filing Date
Wednesday, July 21, 2021
Published for Opposition
Tuesday, May 24, 2022

Trademark Owner History
Astellas Pharma Inc. - Owner At Publication

Classifications
5 Pharmaceutical preparations for the treatment of cancer

Trademark Events
Jan 5, 2024
Notice Of Approval Of Extension Request E-Mailed
Jan 3, 2024
Sou Extension 3 Granted
Jan 3, 2024
Sou Extension 3 Filed
Jan 3, 2024
Sou Teas Extension Received
Jun 28, 2023
Notice Of Approval Of Extension Request E-Mailed
Jun 26, 2023
Sou Extension 2 Granted
Jun 26, 2023
Sou Extension 2 Filed
Jun 26, 2023
Sou Teas Extension Received
Dec 22, 2022
Notice Of Approval Of Extension Request E-Mailed
Dec 20, 2022
Sou Extension 1 Granted
Dec 20, 2022
Sou Extension 1 Filed
Dec 20, 2022
Sou Teas Extension Received
Jul 19, 2022
Noa E-Mailed - Sou Required From Applicant
Jun 3, 2022
Teas Change Of Correspondence Received
Jun 3, 2022
Teas Change Of Domestic Representatives Address
Jun 3, 2022
Attorney/Dom.Rep.Revoked And/Or Appointed
Jun 3, 2022
Teas Revoke/App/Change Addr Of Atty/Dom Rep Received
May 24, 2022
Official Gazette Publication Confirmation E-Mailed
May 24, 2022
Published For Opposition
May 4, 2022
Notification Of Notice Of Publication E-Mailed
Apr 18, 2022
Approved For Pub - Principal Register
Apr 14, 2022
Assigned To Examiner
Sep 22, 2021
New Application Office Supplied Data Entered
Jul 24, 2021
New Application Entered

Trademark Alertz updated from USPTO on 2030-01-24